Risk of reoperative valve surgery for endocarditis associated with drug use.

ABSTRACT:

Background

We aimed to quantify incidence and operative risks associated with reoperative valve surgeries (RVS) in patients with drug-associated infective endocarditis in a multi-center setting.

Methods

We formed a registry of patients with drug-associated infective endocarditis who underwent valve surgeries at 8 US centers between 2011 and 2017. Outcomes of first-time valve surgery (FVS) and RVS were compared. Multivariable logistic regression models related RVS to 30-day mortality. Poisson regression models were fitted to evaluate temporal trends in overall case volume and proportions of patients undergoing RVS.

Results

The cohort consisted of 925 patients with drug-associated infective endocarditis who underwent a valve surgery, of which 652 were FVS and 273 were R

SUBMITTER: Mori M 

PROVIDER: S-EPMC6952585 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature